TuHURA Biosciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $3.6M | $12.7M | $3.7M | $14.3M | $10.5M | $2.4M | $3.7M | $6.0M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $4.6M | $19.6M | $4.2M | $13.3M | $11.8M | $2.9M | $4.0M | $7.0M |
| Property, Plant & Equipment | $300.6K | $123.4K | $182.2K | $90.0K | $150.0K | $2.0K | — | — |
| Goodwill | $10.7M | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | $2.1K | $12.1K | $28.4K |
| Total Assets | $27.4M | $20.0M | $4.4M | $15.9M | $13.5M | $2.9M | $4.0M | $7.1M |
| Liabilities | ||||||||
| Accounts Payable | $3.8M | $3.2M | $1.9M | $3.3M | $2.2M | $2.0M | $1.7M | $1.5M |
| Total Current Liabilities | $5.9M | $5.3M | $3.6M | $4.0M | $2.8M | $2.7M | $2.1M | $1.6M |
| Long-Term Debt | — | — | — | — | — | — | — | $1.1K |
| Total Liabilities | $6.4M | $5.4M | $5.9M | $4.2M | $3.0M | $2.7M | $2.1M | $1.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-141.2M | $-111.1M | $-88.5M | $-136.4M | $-111.2M | $-69.7M | $-60.6M | $-52.4M |
| Total Stockholders' Equity | $20.9M | $14.6M | $-1.6M | $12.3M | $10.6M | $263.0K | $2.0M | $5.4M |